Ken Griffin Champions Oncology, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 3,300 shares of CSBR stock, worth $16,665. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,300
Previous 2,600
26.92%
Holding current value
$16,665
Previous $12,000
41.67%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CSBR
# of Institutions
27Shares Held
5.81MCall Options Held
3.3KPut Options Held
6.1K-
Battery Management Corp. Boston, MA2.42MShares$12.2 Million3.29% of portfolio
-
Nea Management Company, LLC Timonium, MD1.71MShares$8.65 Million0.84% of portfolio
-
Tocqueville Asset Management L.P. New York, NY685KShares$3.46 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA307KShares$1.55 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny123KShares$619,0840.0% of portfolio
About CHAMPIONS ONCOLOGY, INC.
- Ticker CSBR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,522,400
- Market Cap $68.3M
- Description
- Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...